American Healthcare REIT (AHR) Soars 1.20% to Record High on KeyBanc Upgrade

American Healthcare (AHR) experienced a slight decline of 0.56% today, but the share price surged to a record high, with an intraday gain of 1.20%.

The strategy of buying AHR shares after they reached a recent high and holding for 1 week yielded strong results over the past five years. The strategy achieved an overall return of 150.18%, significantly outperforming the benchmark return of 19.63%. The excess return generated by the strategy was 130.56%, indicating that it delivered substantial gains relative to the benchmark. Moreover, the strategy's CAGR was 99.34%, which is a robust indicator of its compounding effectiveness. While the strategy had a maximum drawdown of -12.00%, it maintained a relatively high Sharpe ratio of 3.34, suggesting that the risk-adjusted returns were impressive. The volatility of the strategy was 29.71%, which implies that the strategy's returns were not overly reliant on any single factor and had a broad base of contributors.

KeyBanc has increased its target price for American Healthcare REIT (AHR) from $34 to $40 and maintains an Overweight rating on the stock. This upward revision is reflected in multiple reports, indicating positive analyst sentiment and expected strong price appreciation.

American Healthcare REIT reported a strong financial performance for Q1 2025, with revenue reaching $540.6 million and a 26% increase, which likely contributed to the bullish momentum.